Maryland State Retirement & Pension System’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Buy
8,440
+89
+1% +$4.27K 0.01% 1089
2026
Q1
$432K Hold
8,351
0.01% 919
2025
Q4
$415K Buy
8,351
+290
+4% +$14.1K 0.01% 935
2025
Q3
$385K Sell
8,061
-8,394
-51% -$338K 0.01% 956
2025
Q2
$519K Buy
16,455
+361
+2% +$11.6K 0.01% 930
2025
Q1
$527K Sell
16,094
-2,514
-14% -$89.1K 0.01% 882
2024
Q4
$673K Hold
18,608
0.01% 876
2024
Q3
$580K Sell
18,608
-559
-3% -$17.4K 0.01% 968
2024
Q2
$513K Sell
19,167
-689
-3% -$20K 0.01% 1122
2024
Q1
$588K Hold
19,856
0.01% 1007
2023
Q4
$575K Sell
19,856
-252
-1% -$6.68K 0.01% 1043
2023
Q3
$554K Sell
20,108
-1,116
-5% -$34K 0.01% 989
2023
Q2
$638K Sell
21,224
-545
-3% -$19.1K 0.01% 912
2023
Q1
$789K Sell
21,769
-347
-2% -$13.3K 0.02% 744
2022
Q4
$789K Buy
+22,116
New +$769K 0.02% 685
2022
Q3
Sell
-21,750
Closed -$629K 1215
2022
Q2
$629K Buy
21,750
+239
+1% +$6.84K 0.02% 778
2022
Q1
$695K Buy
21,511
+460
+2% +$14.1K 0.02% 817
2021
Q4
$614K Hold
21,051
0.02% 953
2021
Q3
$560K Buy
+21,051
New +$565K 0.02% 1009

Other funds holding SUPN

Maryland State Retirement & Pension System's SUPN Position: Q2 2026 in Review

Maryland State Retirement & Pension System increased its Supernus Pharmaceuticals (SUPN) stake by 1.1% in Q2 2026, buying an estimated $4.27K and bringing the position to 8,440 shares worth $393K. The position accounts for 0.01% of the portfolio, ranked #1089.

Maryland State Retirement & Pension System first reported a position in SUPN in Q3 2021 and has held it in 19 quarters since. The position peaked at $789K in Q4 2022. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Maryland State Retirement & Pension System held 8,440 shares of Supernus Pharmaceuticals worth $393K as of Q2 2026.
  • Maryland State Retirement & Pension System bought 89 Supernus Pharmaceuticals shares in Q2 2026, an estimated $4.27K.
  • Supernus Pharmaceuticals made up 0.01% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #1089 holding.
  • Maryland State Retirement & Pension System first reported a position in Supernus Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Maryland State Retirement & Pension System's Supernus Pharmaceuticals position peaked at $789K in Q4 2022.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.